Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin in Chemoradiotherapy for Locally Advanced Pancreatic Cancer
NCT00275119Phase 2Unknown
- Sponsor
- GERCOR
- Start
- Nov 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of oxaliplatin in pancreatic cancer (PC), sponsored by GERCOR. Primary endpoint: Progression-Free Survival. Status: unknown.
02
Drugs
oxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00275119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275119.